Laser Technology Could Advance Thyroid Cancer Screening
|
By MedImaging International staff writers Posted on 28 Mar 2016 |
A new, low-cost device could enable enhanced information and better diagnosis during thyroid nodule screening.
A multidisciplinary team that includes The Institute for Photonic Sciences (ICFO; Barcelona, Spain), Politecnico di Milano (Milan, Italy), the University of Birmingham (United Kingdom), along with five other European institutions, are collaborating on the laser and ultrasound co-analyzer for thyroid nodules (LUCA) project, which combines two photonics systems, near-infrared (NIR) diffuse correlation spectroscopy and time-resolved spectroscopy, along with a ultrasound system and a probe that enables multimodal data acquisition.
The project, launched to enhance screening of thyroid nodules for thyroid cancer, brings together clinical endocrinologists, radiologists, physicists, engineers, and industry players with the intention of developing a low-cost, point-of-care clinical device. According to the project partners, LUCA represents an innovative new tool for cancer diagnosis, screening, and therapy, and as such could have a significant impact not only in the field of thyroid cancer, but also in additional areas of the body accessible to both techniques.
“The device combines ultrasound and near-infrared diffuse optical technologies in a single device and a probe. By combining information about tissue hemodynamics, chemical constitution as well as anatomy, it will overcome the shortcomings of present techniques while screening for malign thyroid nodules,” said Prof. Turgut Durduran, PhD, of the ICFO, scientific coordinator of LUCA. “If successful, this will save millions of euros over the coming decades and improve the lives of millions of Europeans.”
“A new tool made concomitantly with thyroid ultrasound may provide additional information to help us distinguish between benign and malignant nodules,” said Mireia Mora, MD, of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS; Barcelona, Spain), responsible for the clinical application of the tool. “This would allow a reduction in the number of surgeries for these reasons, and would have an important socio-economic impact, diminishing the number of surgeries and the associated comorbidities, as well as improving the quality of life of the patients affected.”
Thyroid nodules are a common pathology, with a prevalence of around 5% in women and 1% in men, which increases to 19%–76% with diagnostic neck ultrasound. To exclude thyroid cancer when screening—which occurs in 5%–15% of cases—ultrasound is followed by fine-needle aspiration biopsy of suspicious nodules. In thyroid cancer, the sensitivity and specificity of this process are limited, with a large number of non-diagnostic and false positive results that lead to unnecessary surgery.
Related Links:
Photonic Sciences
Politecnico di Milano
University of Birmingham
A multidisciplinary team that includes The Institute for Photonic Sciences (ICFO; Barcelona, Spain), Politecnico di Milano (Milan, Italy), the University of Birmingham (United Kingdom), along with five other European institutions, are collaborating on the laser and ultrasound co-analyzer for thyroid nodules (LUCA) project, which combines two photonics systems, near-infrared (NIR) diffuse correlation spectroscopy and time-resolved spectroscopy, along with a ultrasound system and a probe that enables multimodal data acquisition.
The project, launched to enhance screening of thyroid nodules for thyroid cancer, brings together clinical endocrinologists, radiologists, physicists, engineers, and industry players with the intention of developing a low-cost, point-of-care clinical device. According to the project partners, LUCA represents an innovative new tool for cancer diagnosis, screening, and therapy, and as such could have a significant impact not only in the field of thyroid cancer, but also in additional areas of the body accessible to both techniques.
“The device combines ultrasound and near-infrared diffuse optical technologies in a single device and a probe. By combining information about tissue hemodynamics, chemical constitution as well as anatomy, it will overcome the shortcomings of present techniques while screening for malign thyroid nodules,” said Prof. Turgut Durduran, PhD, of the ICFO, scientific coordinator of LUCA. “If successful, this will save millions of euros over the coming decades and improve the lives of millions of Europeans.”
“A new tool made concomitantly with thyroid ultrasound may provide additional information to help us distinguish between benign and malignant nodules,” said Mireia Mora, MD, of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS; Barcelona, Spain), responsible for the clinical application of the tool. “This would allow a reduction in the number of surgeries for these reasons, and would have an important socio-economic impact, diminishing the number of surgeries and the associated comorbidities, as well as improving the quality of life of the patients affected.”
Thyroid nodules are a common pathology, with a prevalence of around 5% in women and 1% in men, which increases to 19%–76% with diagnostic neck ultrasound. To exclude thyroid cancer when screening—which occurs in 5%–15% of cases—ultrasound is followed by fine-needle aspiration biopsy of suspicious nodules. In thyroid cancer, the sensitivity and specificity of this process are limited, with a large number of non-diagnostic and false positive results that lead to unnecessary surgery.
Related Links:
Photonic Sciences
Politecnico di Milano
University of Birmingham
Latest General/Advanced Imaging News
- Virtual Staining Technique Creates Histology Images from CT Data
- CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
- AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
- AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
- New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
- Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
- PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
- Multimodal AI Tool Combines CT and Health Records to Predict Heart Risk
- AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
- New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
- 3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
- Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
- Automated AI Tool Detects Early Pancreatic Cancer on Routine CT
- Routine Cardiac CT Enhanced to Predict Heart Failure Risk
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
Myocardial infarction often leaves patients with persistent ventricular dysfunction that can progress without obvious signs. Detecting early decline remains difficult because standard measures may miss... Read more
AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
Multiple sclerosis (MS) causes immune-mediated damage in the brain that leads to disability and cognitive decline. Clinicians have long recognized that lesions in the brain’s gray matter, or cortex, are... Read moreUltrasound
view channel
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read more
AI Ultrasound Platform Receives CE Mark for Prenatal Screening
Prenatal ultrasound is central to fetal anomaly screening, yet it remains one of the most technically demanding examinations in routine care. Because both image acquisition and interpretation are highly... Read moreNuclear Medicine
view channel
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







